HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,463,574 | +14.5% | 60,991 | +8.9% | 0.00% | 0.0% |
| Q2 2023 | $4,770,479 | -0.0% | 56,031 | -2.8% | 0.00% | 0.0% |
| Q1 2023 | $4,770,869 | +2.2% | 57,654 | -2.9% | 0.00% | 0.0% |
| Q4 2022 | $4,668,821 | +4.8% | 59,362 | -1.3% | 0.00% | 0.0% |
| Q3 2022 | $4,453,497 | +10.9% | 60,158 | -2.4% | 0.00% | 0.0% |
| Q2 2022 | $4,016,392 | +1.7% | 61,620 | -1.4% | 0.00% | 0.0% |
| Q1 2022 | $3,949,480 | -9.6% | 62,472 | -24.2% | 0.00% | 0.0% |
| Q4 2021 | $4,369,000 | -25.9% | 82,375 | -1.4% | 0.00% | -40.0% |
| Q3 2021 | $5,895,000 | +6.6% | 83,510 | +0.6% | 0.01% | +25.0% |
| Q2 2021 | $5,532,000 | -81.4% | 83,017 | -69.0% | 0.00% | -84.6% |
| Q1 2021 | $29,688,000 | +8.5% | 267,433 | +16.1% | 0.03% | +4.0% |
| Q4 2020 | $27,358,000 | +32.4% | 230,385 | -2.7% | 0.02% | +19.0% |
| Q3 2020 | $20,660,000 | +19.4% | 236,791 | +20.4% | 0.02% | +31.2% |
| Q2 2020 | $17,300,000 | +68.2% | 196,612 | +90.5% | 0.02% | +45.5% |
| Q1 2020 | $10,284,000 | -10.8% | 103,192 | +2.9% | 0.01% | -8.3% |
| Q4 2019 | $11,528,000 | -11.9% | 100,328 | -4.8% | 0.01% | -20.0% |
| Q3 2019 | $13,080,000 | -6.3% | 105,332 | -9.2% | 0.02% | -6.2% |
| Q2 2019 | $13,962,000 | +38.6% | 116,021 | +0.7% | 0.02% | +45.5% |
| Q1 2019 | $10,077,000 | -16.5% | 115,190 | -4.5% | 0.01% | -26.7% |
| Q4 2018 | $12,074,000 | -10.5% | 120,680 | +2.5% | 0.02% | +7.1% |
| Q3 2018 | $13,487,000 | +24.5% | 117,714 | -2.5% | 0.01% | +16.7% |
| Q2 2018 | $10,830,000 | +274.4% | 120,765 | +205.4% | 0.01% | +300.0% |
| Q1 2018 | $2,893,000 | +23.5% | 39,547 | -1.9% | 0.00% | 0.0% |
| Q4 2017 | $2,342,000 | +32.1% | 40,317 | +2.1% | 0.00% | +50.0% |
| Q3 2017 | $1,773,000 | +12.6% | 39,490 | -1.0% | 0.00% | 0.0% |
| Q2 2017 | $1,575,000 | -1.6% | 39,906 | +1.2% | 0.00% | 0.0% |
| Q1 2017 | $1,600,000 | +14.9% | 39,418 | +13.8% | 0.00% | 0.0% |
| Q4 2016 | $1,392,000 | +10.8% | 34,626 | -0.2% | 0.00% | 0.0% |
| Q3 2016 | $1,256,000 | +25.3% | 34,686 | +0.4% | 0.00% | 0.0% |
| Q2 2016 | $1,002,000 | -15.9% | 34,564 | +0.7% | 0.00% | +100.0% |
| Q1 2016 | $1,192,000 | +10.2% | 34,332 | +2.3% | 0.00% | 0.0% |
| Q4 2015 | $1,082,000 | +0.8% | 33,551 | +1.1% | 0.00% | 0.0% |
| Q3 2015 | $1,073,000 | -19.4% | 33,189 | +3.1% | 0.00% | -50.0% |
| Q2 2015 | $1,331,000 | -13.0% | 32,183 | -5.5% | 0.00% | 0.0% |
| Q1 2015 | $1,530,000 | +23.8% | 34,059 | +3.1% | 0.00% | 0.0% |
| Q4 2014 | $1,236,000 | +5.0% | 33,025 | -2.0% | 0.00% | 0.0% |
| Q3 2014 | $1,177,000 | +2.3% | 33,713 | +3.4% | 0.00% | 0.0% |
| Q2 2014 | $1,151,000 | -8.0% | 32,611 | -15.0% | 0.00% | 0.0% |
| Q1 2014 | $1,251,000 | -22.5% | 38,373 | +0.2% | 0.00% | -33.3% |
| Q4 2013 | $1,614,000 | +4.8% | 38,300 | -0.9% | 0.00% | 0.0% |
| Q3 2013 | $1,540,000 | -6.7% | 38,630 | -3.2% | 0.00% | 0.0% |
| Q2 2013 | $1,651,000 | – | 39,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |